Pfizer announces €1.2bn investment plan for Grange Castle
PFIZER has today announced a €1.2 billion investment into its Grange Castle facility, an expansion set to create hundreds of new jobs.
The investment will see a new facility built at its site in Clondalkin, doubling the capacity for biological drug substance manufacturing.
Construction is expected to begin in 2024 with the plant due for completion by 2027.
Present at this morning’s announcement, Taoiseach Leo Varadkar said: “The pharma sector is such an important part of the Irish economy and the commitment shown by Pfizer to further expand its business here is great news.
“The work undertaken at their facilities across Ireland saves and improves the lives of people all over the world.
“I am very pleased that their presence in Dublin, and indeed in Ireland, continues to go from strength to strength.’’
Pfizer established its first operations in Ireland in Ringaskiddy in 1969.
More than 50 years down the line, it employs around 5,000 people in Ireland, more than 2,000 of whom are based at Grange Castle Business Park.
It has been reported that the €1.2bn investment in Grange Castle will create 400 to 500 new permanent jobs.
IDA Ireland Interim CEO, Mary Buckley said: ‘’Pfizer has had a presence in Ireland for over 50 years and this major additional investment, adding further drug substance capacity to its already substantial Irish operations and jobs, underscores the strategic importance of Ireland in Pfizer’s global operations.
“It is proof of the company’s future commitment to Ireland and testament to Ireland’s continued attractiveness as a location for investment.’’